Institutional & Family Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $43.5K | Hold |
317
| – | – | 0.01% | 258 |
|
|
2024
Q1 | $43.5K | Hold |
317
| – | – | 0.01% | 247 |
|
|
2023
Q4 | $43K | Hold |
317
| – | – | 0.01% | 247 |
|
|
2023
Q3 | $38.7K | Hold |
317
| – | – | 0.01% | 236 |
|
|
2023
Q2 | $40.2K | Hold |
317
| – | – | 0.01% | 238 |
|
|
2023
Q1 | $40.9K | Hold |
317
| – | – | 0.01% | 235 |
|
|
2022
Q4 | $41.6K | Hold |
317
| – | – | 0.01% | 234 |
|
|
2022
Q3 | $37K | Buy |
317
+1
| +0.3% | +$124 | 0.01% | 246 |
|
|
2022
Q2 | $37K | Hold |
316
| – | – | 0.01% | 251 |
|
|
2022
Q1 | $41K | Hold |
316
| – | – | 0.01% | 274 |
|
|
2021
Q4 | $48K | Sell |
316
-145
| -31% | -$22.4K | 0.01% | 269 |
|
|
2021
Q3 | $75K | Buy |
461
+145
| +46% | +$24.4K | 0.01% | 272 |
|
|
2021
Q2 | $52K | Hold |
316
| – | – | 0.01% | 330 |
|
|
2021
Q1 | $48K | Sell |
316
-1,608
| -84% | -$255K | 0.01% | 363 |
|
|
2020
Q4 | $291K | Sell |
1,924
-1
| -0.1% | -$143 | 0.06% | 147 |
|
|
2020
Q3 | $261K | Sell |
1,925
-576
| -23% | -$78.1K | 0.06% | 141 |
|
|
2020
Q2 | $342K | Buy |
2,501
+1,513
| +153% | +$193K | 0.07% | 130 |
|
|
2020
Q1 | $106K | Buy |
988
+1
| +0.1% | +$115 | 0.02% | 198 |
|
|
2019
Q4 | $119K | Sell |
987
-5
| -0.5% | -$558 | 0.03% | 210 |
|
|
2019
Q3 | $99K | Sell |
992
-466
| -32% | -$48.8K | 0.02% | 217 |
|
|
2019
Q2 | $159K | Sell |
1,458
-1,465
| -50% | -$156K | 0.03% | 180 |
|
|
2019
Q1 | $327K | Buy |
2,923
+200
| +7% | +$21.9K | 0.07% | 144 |
|
|
2018
Q4 | $263K | Sell |
2,723
-450
| -14% | -$47.8K | 0.06% | 144 |
|
|
2018
Q3 | $387K | Buy |
3,173
+1
| +0% | +$118 | 0.08% | 136 |
|
|
2018
Q2 | $348K | Buy |
3,172
+774
| +32% | +$82.8K | 0.07% | 137 |
|
|
2018
Q1 | $256K | Sell |
2,398
-1,023
| -30% | -$113K | 0.05% | 155 |
|
|
2017
Q4 | $365K | Sell |
3,421
-836
| -20% | -$89.4K | 0.07% | 128 |
|
|
2017
Q3 | $473K | Buy |
4,257
+2,160
| +103% | +$231K | 0.1% | 128 |
|
|
2017
Q2 | $217K | Sell |
2,097
-3,132
| -60% | -$308K | 0.05% | 120 |
|
|
2017
Q1 | $511K | Sell |
5,229
-9,129
| -64% | -$874K | 0.16% | 93 |
|
|
2016
Q4 | $1.27M | Sell |
14,358
-1,281
| -8% | -$117K | 0.4% | 66 |
|
|
2016
Q3 | $1.51M | Sell |
15,639
-1,371
| -8% | -$130K | 0.5% | 66 |
|
|
2016
Q2 | $1.46M | Buy |
17,010
+1,134
| +7% | +$102K | 0.51% | 67 |
|
|
2016
Q1 | $1.79M | Sell |
15,876
-123
| -0.8% | -$11K | 0.67% | 66 |
|
|
2015
Q4 | $1.8M | Buy |
+15,999
| New | +$1.74M | 0.67% | 66 |
|
Other funds holding IBB
CB
Institutional & Family Asset Management's IBB Position: Q2 2024 in Review
Institutional & Family Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2024 at 317 shares worth $43.5K. The position accounts for 0.01% of the portfolio, ranked #258.
Institutional & Family Asset Management first reported a position in IBB in Q4 2015 and has held it in 35 quarters since. The position peaked at $1.8M in Q4 2015. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.
- Institutional & Family Asset Management held 317 shares of iShares Biotechnology ETF worth $43.5K as of Q2 2024.
- Institutional & Family Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2024.
- iShares Biotechnology ETF made up 0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #258 holding.
- Institutional & Family Asset Management first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 35 quarters since.
- Institutional & Family Asset Management's iShares Biotechnology ETF position peaked at $1.8M in Q4 2015.
- 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.
Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.